NOVABAY PHARMACEUTICALS INC - COM (NBY)

CUSIP: 66987P300

Q4 2023 13F Holders as of 31 Dec 2023

Share change
+931,557
SEC-reported price per share
$0.20
Indexed holders
19
Value change
+$190,829
Number of buys
10
Number of sells
3

Security key

66987P300

Report period

Q4 2023

Indexed institutions

19

Top holders

10

Ownership snapshot

Top reported holders of NBY - NOVABAY PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Xinzhou Li
Disclosed value leader
Andrew D. Jones
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $230,704 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Andrew D. Jones has the largest disclosed position value at $230.7K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Andrew D. Jones's linked filing trail.
Disclosed position value Top 5
Xinzhou Li $54.3K
Andrew D. Jones $230.7K
Justin Hall $150.5K
CITADEL ADVISORS LLC $38.3K
RENAISSANCE TECHNOLOGIES LLC $26K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Xinzhou Li
3/4/5
Director, 10%+ Owner
—
denominator unverified
$54,300
30,000 shares
— 21 May 2021
Andrew D. Jones
3/4/5
CFO
—
denominator unverified
$230,704
127,461 shares
— 15 Feb 2023
Justin Hall
3/4/5
CEO, GC and Director, Director
—
denominator unverified
$150,541
83,172 shares
— 14 Sep 2022
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$38,315
85,145 shares
— 30 Sep 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$26,000
58,823 shares
— 30 Sep 2023
HRT FINANCIAL LP
13F
Company
13F
—
denominator unverified
$22,000
49,024 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
19
Shares
1,189,053
Indexed holders
19
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 indexed holders
13
Q4 2023 indexed holders
19
Indexed holder difference
6
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .